Erythropoietin attenuates pulmonary vascular remodeling in experimental pulmonary arterial hypertension through interplay between endothelial progenitor cells and heme-oxygenase
BackgroundPulmonary arterial hypertension (PAH) is a pulmonary vascular disease with a high mortality, characterized by typical angio-proliferative lesions. Erythropoietin (EPO) attenuates pulmonary vascular remodeling in PAH. We postulated that EPO acts through mobilization of endothelial progenito...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2015-08-01
|
| シリーズ: | Frontiers in Pediatrics |
| 主題: | |
| オンライン・アクセス: | http://journal.frontiersin.org/Journal/10.3389/fped.2015.00071/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
